Covered recipient · General Payments record
ELIZABETH ANN LEIBFREID
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2024
$624.51
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $624.51 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Haemonetics Corporation | $184.57 | 2 |
| Gilead Sciences, Inc. | $121.56 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $116.55 | 1 |
| Ipsen Biopharmaceuticals, Inc | $71.83 | 3 |
| ORPHALAN INC | $68.13 | 4 |
| ABBVIE INC. | $33.70 | 2 |
| Merck Sharp & Dohme Corporation | $14.82 | 1 |
| Relypsa, Inc. | $13.35 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $624.51 | 15 |
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.24 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107526201 | CMS |
| ABBVIE INC. | $16.46 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107526203 | CMS |
| Boston Scientific Corporation | $116.55 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092262770 | CMS |
| Gilead Sciences, Inc. | $121.56 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133711405 | CMS |
| Haemonetics Corporation | $98.28 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143869557 | CMS |
| Haemonetics Corporation | $86.29 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143869559 | CMS |
| Ipsen Biopharmaceuticals, Inc | $24.29 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091987047 | CMS |
| Ipsen Biopharmaceuticals, Inc | $21.38 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091987049 | CMS |
| Ipsen Biopharmaceuticals, Inc | $26.16 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091987045 | CMS |
| Merck Sharp & Dohme LLC | $14.82 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141606457 | CMS |
| ORPHALAN INC | $15.11 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154763345 | CMS |
| ORPHALAN INC | $16.20 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154763647 | CMS |
| ORPHALAN INC | $18.04 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154763895 | CMS |
| ORPHALAN INC | $18.78 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154764174 | CMS |
| Vifor Pharma, Inc. | $13.35 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124063313 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.